These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2381872)

  • 1. Dose-dependent effects of DDAVP on memory in healthy young adult males: a preliminary study.
    Beckwith BE; Till RE; Reno CR; Poland RE
    Peptides; 1990; 11(3):473-6. PubMed ID: 2381872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin analog (DDAVP) improves memory in human males.
    Beckwith BE; Till RE; Schneider V
    Peptides; 1984; 5(4):819-22. PubMed ID: 6494028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin analogue (DDAVP) facilitates recall of narrative prose.
    Beckwith BE; Petros TV; Bergloff PJ; Staebler RJ
    Behav Neurosci; 1987 Jun; 101(3):429-32. PubMed ID: 3606814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of DDAVP on gender-specific verbal and visuospatial tasks in healthy young adults.
    Beckwith BE; Petros TV; Knutson KK
    Peptides; 1990; 11(6):1313-5. PubMed ID: 2087443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment.
    Till RE; Beckwith BE
    Peptides; 1985; 6(3):397-402. PubMed ID: 4070014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers.
    Jacobs GE; van Gerven JM; de Kam Ml; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Hulskotte EG
    J Psychopharmacol; 2011 Mar; 25(3):361-9. PubMed ID: 20147570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers.
    Beckwith BE; Petros TV; Bergloff PJ; Swenson RR; Paulson R
    Peptides; 1995; 16(8):1327-8. PubMed ID: 8745039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.
    Scott LV; Medbak S; Dinan TG
    Biol Psychiatry; 1999 Jun; 45(11):1447-54. PubMed ID: 10356627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal axis modulation: neuroendocrine, cardiovascular and coagulatory effects.
    Jacobs GE; Hulskotte EG; van Gerven JM; Zuurman L; de Kam ML; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Burggraaf J
    J Psychopharmacol; 2011 Mar; 25(3):353-60. PubMed ID: 20142306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DDAVP, a vasopressin analog, on delayed matching behavior in the pigeon.
    Teal JJ; Evans HL
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1123-7. PubMed ID: 7163345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DDAVP on movement planning and execution processes in healthy young adults.
    Carter JS; Williams HG; Davis JM; Rotter RA; Clancy ME
    Peptides; 1991; 12(1):1-5. PubMed ID: 2052484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic vs. acute injection of vasopressin on animal learning and memory.
    Hamburger-Bar R; Klein A; Belmaker RH
    Peptides; 1985; 6(1):23-5. PubMed ID: 3991361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin analog influences the performance of males on a reaction time task.
    Beckwith BE; Couk DI; Till TS
    Peptides; 1983; 4(5):707-9. PubMed ID: 6657514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasopressin on human memory functions.
    Weingartner H; Gold P; Ballenger JC; Smallberg SA; Summers R; Rubinow DR; Post RM; Goodwin FK
    Science; 1981 Feb; 211(4482):601-3. PubMed ID: 7455701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous and intranasal administration of 1-deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity.
    Tryding N; Sterner G; Berg B; Harris A; Lundin S
    Nephron; 1987; 45(1):27-30. PubMed ID: 3808145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH and cortisol release following intravenous desmopressin: a dose-response study.
    Scott LV; Medbak S; Dinan TG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):653-8. PubMed ID: 10594528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
    Vilhardt H; Bie P
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.